Berent J. Prakken
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Berent J. Prakken has a total of 74 co-authors. Here are the top co-authors by number of shared publications:
- Wilco de Jager
Laboratory for Translational Immunology, University Medical Center Utrecht, Utrecht, The Netherlands
6 shared publications Salvatore Albani
Arizona Arthritis Center, University of Arizona, Tucson
4 shared publications- Femke van Wijk
Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
3 shared publications - Aike A. Kruize
University Medical Center Utrecht Department Rheumatology and Clinical Immunology Utrecht Netherlands
2 shared publications - Alessandra Petrelli
Department of Clinical Sciences and Community Health, “Dipartimento di Eccellenza 2023-2027”, University of Milan 1 , Milan, Italy
2 shared publications - Harmieke van Os-Medendorp
Domain of Health, Sports and Social Work Inholland University of Applied Sciences Amsterdam the Netherlands
2 shared publications
Latest Publications
- Open Access
- 2 August 2018
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 128 (10) , 4669-4681
PD-1+CD8+ T cells are clonally expanding effectors in human chronic inflammation
Chronic inflammatory diseases are characterized by recurrent inflammatory attacks in the tissues mediated by autoreactive T cells. Identity and functional programming of CD8+ T cells at the target site of inflammation still remain elusive. One key question is whether, in these antigen-rich environments, chronic stimulation leads to CD8+ T cell exhaustion comparable to what is observed in infectious disease contexts. In the synovial fluid (SF) of juvenile idiopathic arthritis (JIA) patients, a model of chronic inflammation, an overrepresentation of PD-1+CD8+ T cells was found. Gene expression profiling, gene set enrichment analysis, functional studies, and extracellular flux analysis identified PD-1+CD8+ T cells as metabolically active effectors, with no sign of exhaustion. Furthermore, PD-1+CD8+ T cells were enriched for a tissue-resident memory (Trm) cell transcriptional profile and demonstrated increased clonal expansion compared with the PD-1– counterpart, suggesting antigen-driven expansion of locally adapted cells. Interestingly, this subset was also found increased in target tissues in other human chronic inflammatory diseases. These data indicate that local chronic inflammation drives the induction and expansion of CD8+ T cells endowed with potential detrimental properties. Together, these findings lay the basis for investigation of PD-1–expressing CD8+ T cell targeting strategies in human chronic inflammatory diseases.
- 2 August 2018
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 128 (10) , 4669-4681
Open AccessPD-1+CD8+ T cells are clonally expanding effectors in human chronic inflammation
Chronic inflammatory diseases are characterized by recurrent inflammatory attacks in the tissues mediated by autoreactive T cells. Identity and functional programming of CD8+ T cells at the target site of inflammation still remain elusive. One key question is whether, in these antigen-rich environments, chronic stimulation leads to CD8+ T cell exhaustion comparable to what is observed in infectious disease contexts. In the synovial fluid (SF) of juvenile idiopathic arthritis (JIA) patients, a model of chronic inflammation, an overrepresentation of PD-1+CD8+ T cells was found. Gene expression profiling, gene set enrichment analysis, functional studies, and extracellular flux analysis identified PD-1+CD8+ T cells as metabolically active effectors, with no sign of exhaustion. Furthermore, PD-1+CD8+ T cells were enriched for a tissue-resident memory (Trm) cell transcriptional profile and demonstrated increased clonal expansion compared with the PD-1– counterpart, suggesting antigen-driven expansion of locally adapted cells. Interestingly, this subset was also found increased in target tissues in other human chronic inflammatory diseases. These data indicate that local chronic inflammation drives the induction and expansion of CD8+ T cells endowed with potential detrimental properties. Together, these findings lay the basis for investigation of PD-1–expressing CD8+ T cell targeting strategies in human chronic inflammatory diseases.
- Open Access
- 13 October 2017
- Published by Springer Nature in Pediatric Rheumatology
- Vol. 15 (1) , 1-13
Short term effectiveness and experiences of a peer guided web-based self-management intervention for young adults with juvenile idiopathic arthritis
A web-based self-management intervention guided by peer-trainers was developed to support young adults’ self-management in coping with Juvenile Idiopathic Arthritis (JIA). To investigate its effectiveness, a randomized controlled trial (RCT) was conducted. In addition, the content of the chat and participants’ goals were studied to identify underlying processes. An RCT with a six-month follow up period was conducted among 72 young adults with JIA, aged between 16 and 25 years old, randomly assigned to the intervention or to the usual care control group. After 24 weeks, in both groups 24 participants completed all measurements. Intentions to treat analyses were carried out by means of linear mixed models for longitudinal measurements. With self-efficacy as primary outcome, self-management, disease activity, quality of life, absenteeism of school/work, health care medication use and adherence to the intervention were studied. The participants’ goals, personal achievements, interactions on the chat, and their appreciation of the intervention were analyzed using thematic analyses. No significant differences were found on self-efficacy, quality of life, and self-management between the participants of the control group and the intervention group. In the intervention group, modeling and sharing experiences were the most recognized themes. Fifty-five goals were formulated and divided into the following categories: improvement and maintaining balance, setting and recognizing boundaries, communicating and coping with incomprehension. Adherence, appreciation of the own learning experience, and personal achievements were rated positively. The web-based intervention did not lead to an improvement of self-efficacy. However, additional qualitative analyses showed that the intervention was appreciated and valuable for the participants. More research is needed on how to measure the added value of this intervention compared to the usual care. Trial registration number NTR4679 .
- 13 October 2017
- Published by Springer Nature in Pediatric Rheumatology
- Vol. 15 (1) , 1-13
Open AccessShort term effectiveness and experiences of a peer guided web-based self-management intervention for young adults with juvenile idiopathic arthritis
A web-based self-management intervention guided by peer-trainers was developed to support young adults’ self-management in coping with Juvenile Idiopathic Arthritis (JIA). To investigate its effectiveness, a randomized controlled trial (RCT) was conducted. In addition, the content of the chat and participants’ goals were studied to identify underlying processes. An RCT with a six-month follow up period was conducted among 72 young adults with JIA, aged between 16 and 25 years old, randomly assigned to the intervention or to the usual care control group. After 24 weeks, in both groups 24 participants completed all measurements. Intentions to treat analyses were carried out by means of linear mixed models for longitudinal measurements. With self-efficacy as primary outcome, self-management, disease activity, quality of life, absenteeism of school/work, health care medication use and adherence to the intervention were studied. The participants’ goals, personal achievements, interactions on the chat, and their appreciation of the intervention were analyzed using thematic analyses. No significant differences were found on self-efficacy, quality of life, and self-management between the participants of the control group and the intervention group. In the intervention group, modeling and sharing experiences were the most recognized themes. Fifty-five goals were formulated and divided into the following categories: improvement and maintaining balance, setting and recognizing boundaries, communicating and coping with incomprehension. Adherence, appreciation of the own learning experience, and personal achievements were rated positively. The web-based intervention did not lead to an improvement of self-efficacy. However, additional qualitative analyses showed that the intervention was appreciated and valuable for the participants. More research is needed on how to measure the added value of this intervention compared to the usual care. Trial registration number NTR4679 .
- Open Access
- 29 November 2016
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 14 (1) , 1-4
Developing translational medicine professionals: the Marie Skłodowska-Curie action model
End goal of translational medicine is to combine disciplines and expertise to eventually promote improvement of the global healthcare system by delivering effective therapies to individuals and society. Well-trained experts of the translational medicine process endowed with profound knowledge of biomedical technology, ethical and clinical issues, as well as leadership and teamwork abilities are essential for the effective development of tangible therapeutic products for patients. In this article we focus on education and, in particular, we discuss how programs providing training on the broad spectrum of the translational medicine continuum have still a limited degree of diffusion and do not provide professional support and mentorship in the long-term, resulting in the lack of well established professionals of translational medicine (TMPs) in the scientific community. Here, we describe the Marie Skłodowska-Curie Actions program ITN-EUtrain (EUropean Translational tRaining for Autoimmunity & Immune manipulation Network) where training on the Translational Medicine machinery was integrated with education on professional and personal skills, mentoring, and a long-lasting network of TMPs.
- 29 November 2016
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 14 (1) , 1-4
Open AccessDeveloping translational medicine professionals: the Marie Skłodowska-Curie action model
End goal of translational medicine is to combine disciplines and expertise to eventually promote improvement of the global healthcare system by delivering effective therapies to individuals and society. Well-trained experts of the translational medicine process endowed with profound knowledge of biomedical technology, ethical and clinical issues, as well as leadership and teamwork abilities are essential for the effective development of tangible therapeutic products for patients. In this article we focus on education and, in particular, we discuss how programs providing training on the broad spectrum of the translational medicine continuum have still a limited degree of diffusion and do not provide professional support and mentorship in the long-term, resulting in the lack of well established professionals of translational medicine (TMPs) in the scientific community. Here, we describe the Marie Skłodowska-Curie Actions program ITN-EUtrain (EUropean Translational tRaining for Autoimmunity & Immune manipulation Network) where training on the Translational Medicine machinery was integrated with education on professional and personal skills, mentoring, and a long-lasting network of TMPs.
- Open Access
- 7 February 2013
- Published by Springer Nature in Journal of Neuroinflammation
- Vol. 10 (1) , 24
Cerebral ischemia initiates an immediate innate immune response in neonates during cardiac surgery
A robust inflammatory response occurs in the hours and days following cerebral ischemia. However, little is known about the immediate innate immune response in the first minutes after an ischemic insult in humans. We utilized the use of circulatory arrest during cardiac surgery to assess this.
- 7 February 2013
- Published by Springer Nature in Journal of Neuroinflammation
- Vol. 10 (1) , 24
Open AccessCerebral ischemia initiates an immediate innate immune response in neonates during cardiac surgery
A robust inflammatory response occurs in the hours and days following cerebral ischemia. However, little is known about the immediate innate immune response in the first minutes after an ischemic insult in humans. We utilized the use of circulatory arrest during cardiac surgery to assess this.
- Open Access
- 1 January 2013
- Published by Wiley in Clinical and Translational Allergy
- Vol. 3 (1) , 40
Plasma IL‐25 is elevated in a subgroup of patients with clinical reactivity to peanut
Background: One of the IL‐17 family members, IL‐25, has been implicated with the initiation and amplification of Th2 responses in animal models and has been associated with airway hyper‐reactivity. The involvement of IL‐25 and also IL‐17 in food allergic disease remains to be investigated.Findings: In this study thirty children suspected of peanut allergic disease underwent a double‐blind placebo controlled food challenge (DBPCFC) and IL‐25 and IL‐17 plasma levels were determined before and after challenge. IL‐25 was highly elevated only in subgroup of children with a positive DBPCFC outcome. Plasma IL‐25 was absent in children with a negative DBPCFC outcome and in healthy controls.Conclusions: This study shows that IL‐25, an IL‐17 family member, is highly elevated only in children with a clinical response to peanut. This suggests a role for IL‐25 in the pathogenesis of peanut allergy and elevated plasma IL‐25 may be a sign of a severe atopic phenotype.
- 1 January 2013
- Published by Wiley in Clinical and Translational Allergy
- Vol. 3 (1) , 40
Open AccessPlasma IL‐25 is elevated in a subgroup of patients with clinical reactivity to peanut
Background: One of the IL‐17 family members, IL‐25, has been implicated with the initiation and amplification of Th2 responses in animal models and has been associated with airway hyper‐reactivity. The involvement of IL‐25 and also IL‐17 in food allergic disease remains to be investigated.Findings: In this study thirty children suspected of peanut allergic disease underwent a double‐blind placebo controlled food challenge (DBPCFC) and IL‐25 and IL‐17 plasma levels were determined before and after challenge. IL‐25 was highly elevated only in subgroup of children with a positive DBPCFC outcome. Plasma IL‐25 was absent in children with a negative DBPCFC outcome and in healthy controls.Conclusions: This study shows that IL‐25, an IL‐17 family member, is highly elevated only in children with a clinical response to peanut. This suggests a role for IL‐25 in the pathogenesis of peanut allergy and elevated plasma IL‐25 may be a sign of a severe atopic phenotype.
- 3 December 2012
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 171 (1) , 20-29
Heat shock protein bystander antigens for peptide immunotherapy in autoimmune disease
Summary: Mucosal administration of an antigen eliciting bystander suppression at the site of inflammation results in effective antigen-specific immunotherapy for autoimmune diseases. Heat shock proteins are bystander antigens that are effective in peptide-specific immunotherapy in both experimental and human autoimmune disease. The efficacy of preventive peptide immunotherapy is increased by enhancing peptide-specific immune responses with proinflammatory agents. Combining peptide-specific immunotherapy with general suppression of inflammation may improve its therapeutic effect.
- 3 December 2012
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 171 (1) , 20-29
Heat shock protein bystander antigens for peptide immunotherapy in autoimmune disease
Summary: Mucosal administration of an antigen eliciting bystander suppression at the site of inflammation results in effective antigen-specific immunotherapy for autoimmune diseases. Heat shock proteins are bystander antigens that are effective in peptide-specific immunotherapy in both experimental and human autoimmune disease. The efficacy of preventive peptide immunotherapy is increased by enhancing peptide-specific immune responses with proinflammatory agents. Combining peptide-specific immunotherapy with general suppression of inflammation may improve its therapeutic effect.
- Open Access
- 29 June 2009
- Published by Wiley in Arthritis & Rheumatism
- Vol. 60 (7) , 1966-1976
PAN–DR‐Binding Hsp60 self epitopes induce an interleukin‐10–mediated immune response in rheumatoid arthritis
Objective Human Hsp60 is expressed in the joints of patients with rheumatoid arthritis (RA) and can elicit a regulatory T cell response in the peripheral blood and synovial fluid. However, Hsp60 can also trigger strong proinflammatory pathways. Thus, to understand the nature of these Hsp60-directed responses in RA, it is necessary to study such responses at the molecular, epitope-specific level. This study was undertaken to characterize the disease specificity and function of pan–DR-binding Hsp60–derived epitopes as possible modulators of autoimmune inflammation in RA. Methods Lymphocyte proliferation assays (using 3H-thymidine incorporation and carboxyfluorescein diacetate succinimidyl ester [CFSE] staining) and measurement of cytokine production (using multiplex immunoassay and intracellular staining) were performed after in vitro activation of peripheral blood mononuclear cells from patients with RA, compared with healthy controls. Results A disease (RA)–specific immune recognition, characterized by T cell proliferation as well as increased production of tumor necrosis factor α (TNFα), interleukin-1β (IL-1β), and IL-10, was found for 3 of the 8 selected peptides in patients with RA as compared with healthy controls (P < 0.05). Intracellular cytokine staining and CFSE labeling showed that CD4+ T cells were the subset primarily responsible for both the T cell proliferation and the cytokine production in RA. Interestingly, the human peptides had a remarkably different phenotype, with a 5–10-fold higher IL-10:TNFα ratio, compared with that of the microbial peptides. Conclusion These results suggest a disease-specific immune-modulatory role of epitope-specific T cells in the inflammatory processes of RA. Therefore, these pan–DR-binding epitopes could be used as a tool to study the autoreactive T cell response in RA and might be suitable candidates for use in immunotherapy.
- 29 June 2009
- Published by Wiley in Arthritis & Rheumatism
- Vol. 60 (7) , 1966-1976
Open AccessPAN–DR‐Binding Hsp60 self epitopes induce an interleukin‐10–mediated immune response in rheumatoid arthritis
Objective Human Hsp60 is expressed in the joints of patients with rheumatoid arthritis (RA) and can elicit a regulatory T cell response in the peripheral blood and synovial fluid. However, Hsp60 can also trigger strong proinflammatory pathways. Thus, to understand the nature of these Hsp60-directed responses in RA, it is necessary to study such responses at the molecular, epitope-specific level. This study was undertaken to characterize the disease specificity and function of pan–DR-binding Hsp60–derived epitopes as possible modulators of autoimmune inflammation in RA. Methods Lymphocyte proliferation assays (using 3H-thymidine incorporation and carboxyfluorescein diacetate succinimidyl ester [CFSE] staining) and measurement of cytokine production (using multiplex immunoassay and intracellular staining) were performed after in vitro activation of peripheral blood mononuclear cells from patients with RA, compared with healthy controls. Results A disease (RA)–specific immune recognition, characterized by T cell proliferation as well as increased production of tumor necrosis factor α (TNFα), interleukin-1β (IL-1β), and IL-10, was found for 3 of the 8 selected peptides in patients with RA as compared with healthy controls (P < 0.05). Intracellular cytokine staining and CFSE labeling showed that CD4+ T cells were the subset primarily responsible for both the T cell proliferation and the cytokine production in RA. Interestingly, the human peptides had a remarkably different phenotype, with a 5–10-fold higher IL-10:TNFα ratio, compared with that of the microbial peptides. Conclusion These results suggest a disease-specific immune-modulatory role of epitope-specific T cells in the inflammatory processes of RA. Therefore, these pan–DR-binding epitopes could be used as a tool to study the autoreactive T cell response in RA and might be suitable candidates for use in immunotherapy.
- Open Access
- 1 March 2009
- Published by Elsevier in Cell Stress and Chaperones
- Vol. 14 (2) , 117-131
Hsp70 and cardiac surgery: molecular chaperone and inflammatory regulator with compartmentalized effects
- 1 March 2009
- Published by Elsevier in Cell Stress and Chaperones
- Vol. 14 (2) , 117-131
Open AccessHsp70 and cardiac surgery: molecular chaperone and inflammatory regulator with compartmentalized effects
- Top Cited PapersOpen Access
- 1 January 2009
- Published by Springer Nature in BMC Immunology
- Vol. 10 (1) , 52
Prerequisites for cytokine measurements in clinical trials with multiplex immunoassays
Growing knowledge about cellular interactions in the immune system, including the central role of cytokine networks, has lead to new treatments using monoclonal antibodies that block specific components of the immune system. Systemic cytokine concentrations can serve as surrogate outcome parameters of these interventions to study inflammatory pathways operative in patients in vivo. This is now possible due to novel technologies such as multiplex immunoassays (MIA) that allows detection of multiple cytokines in a single sample. However, apparently trivial underappreciated processes, (sample handling and storage, interference of endogenous plasma proteins) can greatly impact the reliability and reproducibility of cytokine detection.
- 1 January 2009
- Published by Springer Nature in BMC Immunology
- Vol. 10 (1) , 52
Top Cited PapersOpen AccessPrerequisites for cytokine measurements in clinical trials with multiplex immunoassays
Growing knowledge about cellular interactions in the immune system, including the central role of cytokine networks, has lead to new treatments using monoclonal antibodies that block specific components of the immune system. Systemic cytokine concentrations can serve as surrogate outcome parameters of these interventions to study inflammatory pathways operative in patients in vivo. This is now possible due to novel technologies such as multiplex immunoassays (MIA) that allows detection of multiple cytokines in a single sample. However, apparently trivial underappreciated processes, (sample handling and storage, interference of endogenous plasma proteins) can greatly impact the reliability and reproducibility of cytokine detection.